top of page
Starting August 1, 2024, Quickarrays, Inc. will be providing all products and services in place of Pantomics Inc.
SERVICES
CUSTOM TMA
ROUTINE PATHOLOGY
IHC / IMMUNOFLUORESCENCE
ISH / FISH
CONTRACTED SERVICES
PRIMARY IHC ANTIBODIES
PATHOLOGY FIELD
Hermatopathology
DETECTION SYSTEMS
ANCILLARIES
CONTROL TMA
LVC961
Liver cancer tissue array, set 1, non-overlapping with LVC962, 96 cores, 48 cases from normal, premalignant and cancer tissues with progressive grades and TNM stages in duplicates.
Specification
Data Sheet
TNM Grading
Downloads
Price
Size
Availability
$298
1 slide
In-Stock
A | |
B | |
C | |
D | |
E | |
F | |
G | |
H | |
TNM Classification : Liver carcinoma
T- Primary tumor
TX - Primary tumor cannot be assessed
TO - No evidence of primary tumor
T1 - Solitary tumor without vascular invasion
T2 - Solitary tumor with vascular invasion or multiple tumors none larger than 5cm
T3 - Multiple tumors more than 5 cm, or tumor involving a major branch of the portal or hepatic vein(s)
T4 - Tumor(s) with direct invasion of adjacent organs other than the gallbladder or with perforation of visceral peritoneum
N - Regional lymph nodes
NX - Regional lymph nodes cannot be assessed
NO - No regional lymph node metastasis
N1 - Regional lymph node metastasis
M - Distant metastasis
MX - Distant metastasis cannot be assessed
MO - No distant metastasis
M1 - Distant metastasis
Human
48
96
1.5mm
4um
8
12
Paraffin
Notes:
All tissues were fixed in 10% neutral buffered formalin for 24 hours and processed using identical SOPs. Sections were picked onto Superfrost Plus or Startfrost Adhesive slides. They all have a guaranteed six month shelf-life at 4C from the date of shipment. Additional cores not listed are orientation markers and have no data. There maybe <5% core loss per slide but the core retention rate should be >90%.
Bake at 60C for 30 minutes before use. If antigen retrieving is needed, it is always a good idea to start with a protocol with weak to mild strength. Please check our TNM guide as a reference. For IHC related information on products that provide them, please contact us at info@pantomics.com for the most up-to-date information.
For research use only. Designed for IHC or ISH based protein or RNA tissue profiling in evolution and progression of liver cancers.
ARRAY POSITION | IMAGE | SEX | AGE | ANATOMIC SITE | PATHOLOGY | GRADE | STAGE (TNM) |
|---|---|---|---|---|---|---|---|
A01 | M | 40 | Liver | Normal | |||
A02 | M | 63 | Liver | Normal | |||
A03 | F | 37 | Liver | Normal | |||
A04 | M | 56 | Liver | Cellular swelling | |||
A05 | M | 51 | Liver | Cellular swelling | |||
A06 | M | 59 | Liver | Chronic viral hepatitis | |||
A07 | M | 50 | Liver | Viral subfulminant hepatitis | |||
A08 | M | 52 | Liver | Viral subfulminant hepatitis | |||
A09 | F | 56 | Liver | Viral hepatitis related cirrhosis | |||
A10 | M | 57 | Liver | Viral hepatitis related cirrhosis | |||
A11 | M | 29 | Liver | Viral hepatitis related cirrhosis | |||
A12 | M | 37 | Liver | Hemangioma | |||
B01 | M | 40 | Liver | Normal | |||
B02 | M | 63 | Liver | Normal | |||
B03 | F | 37 | Liver | Normal | |||
B04 | M | 56 | Liver | Cellular swelling | |||
B05 | M | 51 | Liver | Cellular swelling | |||
B06 | M | 59 | Liver | Chronic viral hepatitis | |||
B07 | M | 50 | Liver | Viral subfulminant hepatitis | |||
B08 | M | 52 | Liver | Viral subfulminant hepatitis | |||
B09 | F | 56 | Liver | Viral hepatitis related cirrhosis | |||
B10 | M | 57 | Liver | Viral hepatitis related cirrhosis | |||
B11 | M | 29 | Liver | Viral hepatitis related cirrhosis | |||
B12 | M | 37 | Liver | Hemangioma | |||
C01 | M | 40 | Liver | Hepatocellular carcinoma | I | T2N0M0 | |
C02 | M | 67 | Liver | Hepatocellular carcinoma | I | T2N0M0 | |
C03 | M | 26 | Liver | Hepatocellular carcinoma | I | T2N0M0 | |
C04 | M | 66 | Liver | Hepatocellular carcinoma | I | T2N0M0 | |
C05 | M | 78 | Liver | Hepatocellular carcinoma | II | T3N0M0 | |
C06 | M | 65 | Liver | Hepatocellular carcinoma | I | T2N0M0 | |
C07 | M | 43 | Liver | Hepatocellular carcinoma | II | T2N0M0 | |
C08 | M | 63 | Liver | Hepatocellular carcinoma | II | T2N0M0 | |
C09 | M | 35 | Liver | Hepatocellular carcinoma | II | T3N0M0 | |
C10 | M | 29 | Liver | Hepatocellular carcinoma | II | T4N0M0 | |
C11 | M | 40 | Liver | Hepatocellular carcinoma | II | T2N0M0 | |
C12 | M | 55 | Liver | Hepatocellular carcinoma | II | T2N0M0 | |
D01 | M | 40 | Liver | Hepatocellular carcinoma | I | T2N0M0 | |
D02 | M | 67 | Liver | Hepatocellular carcinoma | I | T2N0M0 | |
D03 | M | 26 | Liver | Hepatocellular carcinoma | I | T2N0M0 | |
D04 | M | 66 | Liver | Hepatocellular carcinoma | I | T2N0M0 | |
D05 | M | 78 | Liver | Hepatocellular carcinoma | II | T3N0M0 | |
D06 | M | 65 | Liver | Hepatocellular carcinoma | I | T2N0M0 | |
D07 | M | 43 | Liver | Hepatocellular carcinoma | II | T2N0M0 | |
D08 | M | 63 | Liver | Hepatocellular carcinoma | II | T2N0M0 | |
D09 | M | 35 | Liver | Hepatocellular carcinoma | II | T3N0M0 | |
D10 | M | 29 | Liver | Hepatocellular carcinoma | II | T4N0M0 | |
D11 | M | 40 | Liver | Hepatocellular carcinoma | II | T2N0M0 | |
D12 | M | 55 | Liver | Hepatocellular carcinoma | II | T2N0M0 | |
E01 | M | 56 | Liver | Hepatocellular carcinoma | II | T3N0M0 | |
E02 | F | 60 | Liver | Hepatocellular carcinoma | II | T2N0M0 | |
E03 | M | 56 | Liver | Hepatocellular carcinoma | II | T2N0M0 | |
E04 | M | 45 | Liver | Hepatocellular carcinoma | II | T2N0M0 | |
E05 | F | 32 | Liver | Hepatocellular carcinoma | II | T3N0M0 | |
E06 | M | 44 | Liver | Hepatocellular carcinoma | II | T2N0M0 | |
E07 | M | 31 | Liver | Hepatocellular carcinoma | III | T2N0M0 | |
E08 | M | 53 | Liver | Hepatocellular carcinoma | III | T2N0M0 | |
E09 | M | 31 | Liver | Hepatocellular carcinoma | III | T2N0M0 | |
E10 | M | 57 | Liver | Hepatocellular carcinoma | III | T2N0M0 | |
E11 | M | 37 | Liver | Hepatocellular carcinoma | III | T2N0M0 | |
E12 | M | 38 | Liver | Hepatocellular carcinoma | II~III | T2N0M0 | |
F01 | M | 56 | Liver | Hepatocellular carcinoma | II | T3N0M0 | |
F02 | F | 60 | Liver | Hepatocellular carcinoma | II | T2N0M0 | |
F03 | M | 56 | Liver | Hepatocellular carcinoma | II | T2N0M0 | |
F04 | M | 45 | Liver | Hepatocellular carcinoma | II | T2N0M0 | |
F05 | F | 32 | Liver | Hepatocellular carcinoma | II | T3N0M0 | |
F06 | M | 44 | Liver | Hepatocellular carcinoma | II | T2N0M0 | |
F07 | M | 31 | Liver | Hepatocellular carcinoma | III | T2N0M0 | |
F08 | M | 53 | Liver | Hepatocellular carcinoma | III | T2N0M0 | |
F09 | M | 31 | Liver | Hepatocellular carcinoma | III | T2N0M0 | |
F10 | M | 57 | Liver | Hepatocellular carcinoma | III | T2N0M0 | |
F11 | M | 37 | Liver | Hepatocellular carcinoma | III | T2N0M0 | |
F12 | M | 38 | Liver | Hepatocellular carcinoma | II~III | T2N0M0 | |
G01 | M | 55 | Liver | Hepatocellular carcinoma | III | T1N0M0 | |
G02 | M | 34 | Liver | Hepatocellular carcinoma | T2N0M0 | ||
G03 | M | 32 | Liver | Hepatocellular carcinoma | T3N0M0 | ||
G04 | M | 65 | Liver | Hepatocellular carcinoma, clear cell type | II | T2N0M0 | |
G05 | F | 70 | Liver | Cholangiocarcinoma | II | T3N0M0 | |
G06 | M | 39 | Liver | Cholangiocarcinoma | II~III | T2N0M0 | |
G07 | F | 69 | Liver | Cholangiocarcinoma | II | T4N1M0 | |
G08 | M | 51 | Liver | Cholangiocarcinoma | II | T2N0M0 | |
G09 | M | 57 | Liver | Metastatic colon adenocarcinoma | |||
G10 | M | 57 | Liver | Metastatic adenocarcinoma | |||
G11 | M | 42 | Liver | Metastatic adenocarcinoma | |||
G12 | M | 43 | Liver | Leiomyosarcoma | |||
H01 | M | 55 | Liver | Hepatocellular carcinoma | III | T1N0M0 | |
H02 | M | 34 | Liver | Hepatocellular carcinoma | T2N0M0 | ||
H03 | M | 32 | Liver | Hepatocellular carcinoma | T3N0M0 | ||
H04 | M | 65 | Liver | Hepatocellular carcinoma, clear cell type | II | T2N0M0 | |
H05 | F | 70 | Liver | Cholangiocarcinoma | II | T3N0M0 | |
H06 | M | 39 | Liver | Cholangiocarcinoma | II~III | T2N0M0 | |
H07 | F | 69 | Liver | Cholangiocarcinoma | II | T4N1M0 | |
H08 | M | 51 | Liver | Cholangiocarcinoma | II | T2N0M0 | |
H09 | M | 57 | Liver | Metastatic colon adenocarcinoma | |||
H10 | M | 57 | Liver | Metastatic adenocarcinoma | |||
H11 | M | 42 | Liver | Metastatic adenocarcinoma | |||
H12 | M | 43 | Liver | Leiomyosarcoma | |||
null |
bottom of page